Omega Therapeutics, Inc. (OMGA) Stock Analysis
DELISTED
What happened to Omega Therapeutics, Inc. (OMGA) stock?
Omega Therapeutics, Inc. (OMGA) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $7.90M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Omega Therapeutics, Inc. (OMGA). Omega Therapeutics, Inc. is a development-stage biopharmaceutical company focused on epigenomic programming. Their OMEGA platform aims to control gene expression for treating various diseases.
Last analyzed: Mar 16, 2026Omega Therapeutics, Inc. (OMGA) Healthcare & Pipeline Overview
More about this archive record
Can I still buy OMGA shares?
No. OMGA stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for OMGA elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OMGA stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Omega Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.